June 1, 2020 / 12:37 PM / a month ago

BRIEF-Eisai Announces U.S. Availability Of DAYVIGO (lemborexant) CIV

June 1 (Reuters) - Eisai Co Ltd:

* EISAI ANNOUNCES U.S. AVAILABILITY OF DAYVIGO® (LEMBOREXANT) CIV, A NEW TREATMENT OPTION FOR ADULTS WITH INSOMNIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below